Balie and Salve investigated the development of transdermal films embedded with selegiline (a selective inhibitor of MAO-B taken in combination with levodopa to slow progression of PD) loaded into PLGA nanoparticles (S-PLGA) for sustained treatment of PD128. This evidence concerns the gene MAOB and Parkinson disease.